Montana: Cannabis & Alcohol Regulation Division: A Year in Review
One year after the cannabis and alcohol divisions merged, read what CARD has done and what’s planned for Year Two.

200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
One year after the cannabis and alcohol divisions merged, read what CARD has done and what’s planned for Year Two.

Of course offering extra cash this quickly into the game suggests a certain sense of desperation on the part of Boris & team

Joint Agreement Positions Rolling Paper and Accessories Brand for Future Expansion into Cannabis Genetics, Seeds and Culture-Driven Product Innovation

I think of it like this video except when you finally open it the gift is a lovely military drone that can kill all these kids.

Yep ,the nexus of the middle east Cannabis, weaponry and mioney, same as it always was.

VANCOUVER, British Columbia, Sept. 14, 2026 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the appointment of Deepak Anand as Vice President of Government…

Cresco Labs is the latest marijuana multistate operator to scoop up assets from flailing competitor PharmaCann, this time in medical marijuana-only Pennsylvania.

Curaleaf’s self-serving portrayal of our business is an attempt to acquire Aurora’s world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible

Curaleaf Holdings plans to solidify its position as the global cannabis industry leader by offering to purchase all of Aurora Cannabis’ issued and outstanding common shares, the company announced Aug. 11.

, Aug. 5, 2026 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today reported its financial and operating results…

BOSTON, July 27, 2026 (GLOBE NEWSWIRE) — Rose Hill Life Sciences (“Rose Hill” or “the Company”), a clinical-stage biotechnology company advancing psychedelic therapeutics for neurological and psychiatric conditions, announced the…
